Literature DB >> 6264601

Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization.

R J Massey, G Schochetman.   

Abstract

The inability of pathogenic animal viruses to be completely neutralized by antibodies can lead to chronic viral infections in which infectious virus persists even in the presence of excess neutralizing antibody. A mechanism that results in this nonneutralized fraction of virus was defined by the topographical relationships of viral epitopes identified with monoclonal antibodies wherein monoclonal antibodies bind to virus and sterically block the binding of neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264601     DOI: 10.1126/science.6264601

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

1.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.

Authors:  U Utz; W Britt; L Vugler; M Mach
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  A serum protein affecting the regulation of the immune system.

Authors:  D Karcher; A Lowenthal; P Stoppie; M Noppe
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

4.  Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen.

Authors:  A R Neurath; S B Kent; N Strick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity.

Authors:  W A Volk; R M Synder; D C Benjamin; R R Wagner
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

6.  Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.

Authors:  N C Pedersen; L Johnson; D Birch; G H Theilen
Journal:  Vet Immunol Immunopathol       Date:  1986-02       Impact factor: 2.046

7.  Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6.

Authors:  F Verrier; A Nádas; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Identification of a cellular receptor for mouse mammary tumor virus and mapping of its gene to chromosome 16.

Authors:  J Hilkens; B van der Zeijst; F Buijs; V Kroezen; N Bleumink; J Hilgers
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

9.  Neutralizing antibody response of rabbits and goats to caprine arthritis-encephalitis virus.

Authors:  P Klevjer-Anderson; T C McGuire
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies.

Authors:  L J Anderson; P Bingham; J C Hierholzer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.